好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Prevalence and Overlap of Potential Embolic Sources in Embolic Stroke of Undetermined Source in Tunisia
Cerebrovascular Disease and Interventional Neurology
P7 - Poster Session 7 (8:00 AM-9:00 AM)
13-003

We  aimed to assess the prevalence and degree of overlap of the   PES   in Tunisian  patients with ESUS . 

 In 2014, researchers have proposed the concept of Embolic Stroke of Undetermined Source (ESUS) , which is defined as a nonlacunar brain infarct without a significant  stenosis of extracranial or intracranial arteries or  major  cardioembolic sources. ESUS represents an etiologically heterogeneous group and may be caused by various potential  embolic sources (PES) . 

A retrospective analysis of prospectively collected acute ischemic stroke data from 2017 to 2020 was performed. We identified  patients who met the ESUS diagnostic criteria according to the criteria of the Cryptogenic Stroke/ESUS International Working Group.  We assessed the presence/absence of each PES (atrial cardiopathy, atrial fibrillation diagnosed during follow-up, arterial atherosclerosis stenosis with <50%, left ventricular dysfunction, cardiac valvulopathy, patent foramen ovale, cancer-associated) . Patients were categorized in ≥1 groups according to the identified PES . The outcome was ischemic stroke recurrence during follow-up.

Among 330 admitted  patients , 66 (20%) were classified as ESUS (31.8 % women, mean age 57.09 ± 11 years). Among potential causes of the ESUS, the 3 most prevalent PES were atrial cardiopathy (71.2%), arterial atherosclerosis (41.6%) and left ventricular disease (39.4%).  Most patients (84.8%) had ≥ 2 PES, whereas only 6.1% and 9.1% of patients had a single or no PES, respectively. During a median follow-up of 16 months, ischemic stroke recurrence occurred in 15.2% of patients. In multivariate analysis, the risk of stroke recurrence was higher in the atrial fibrillation group compared with other PES, but not statistically different between patients with 0 to 1, 2, or ≥3 PES.

 Most patients with ESUS had multiple PES , which overlap considerably.   This finding  may  explain the the negative   results of large trials  of secondary prevention in  ESUS population .  
Authors/Disclosures

PRESENTER
No disclosure on file
No disclosure on file
No disclosure on file
Mahouba Frih (University Hospital Fattouma Bourguiba Monastir) MAHBOUBA FRIH has nothing to disclose.